An arrhythmia is a heart rhythm that is irregular, too fast, or too slow. Transient idiopathic arrhythmia is a type of temporary irregular heart rhythm that does not have a cause doctors can identify.

Occasional episodes of abnormal heart rhythms may not be concerning, but in many cases some type of treatment is necessary to avoid serious complications. Usually, the heart beats in a steady rhythm ...

Events like panic attacks or low blood sugar can sometimes mimic arrhythmia symptoms. Several other conditions can contribute to, occur alongside, or result from arrhythmia. An arrhythmia is the ...

A heart arrhythmia is when your heart beats too fast, too slow, or out of sync. Some arrhythmias can be genetic. A genetic arrhythmia happens when one or both of your parents pass down a gene change ...

A cardiac arrhythmia refers to any abnormality in the heart's rate or rhythm. There are many different types of arrhythmias, some much more serious than others. A minor arrhythmia may cause you to ...

Health care professionals should become more familiar with medications that cause irregular heart rhythms called arrhythmias, according to "Drug-Induced Arrhythmias," a new scientific statement from ...

Irregular heartbeats, or arrhythmia, can significantly affect a person’s quality of life and overall health. When medication and lifestyle changes are ineffective, doctors may recommend surgery to ...

On the heels of acquiring a catheter hardware developer and announcing a slew of new partnerships, Acutus Medical has now secured $170 million to move further into heart arrhythmia treatment delivery ...

Tests for Detecting Arrhythmias Electrocardiogram (ECG or EKG). A record of the electrical activity of the heart. Disks are placed on the chest and connected by wires to a recording machine. The heart ...

Arrhythmia-focused Acutus Medical is moving to acquire catheter developer Rhythm Xience while launching a handful of new strategic partnerships as it looks to expand its portfolio beyond its heart ...

Company to hold conference today at 8:00 a.m. -- BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc.